Metastatic osteosarcoma is characterized by more aggressive tumor behavior, often associated with a higher degree of systemic inflammation.1, 16The markers identified in the present study (CRP, ESR, NLR, and LDH) reflect distinct yet interconnected aspects of this inflammatory response, providing insight into the mechanisms by which inflammation may drive metastatic progression. Here, CRP is linked to osteosarcoma.